-
Views
-
Cite
Cite
Takuya Ohba, Yuta Yoshino, Mitsue Ishisaka, Naohito Abe, Kazuhiro Tsuruma, Masamitsu Shimazawa, Masayoshi Oyama, Takeshi Tabira, Hideaki Hara, Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice, Bioscience, Biotechnology, and Biochemistry, Volume 79, Issue 11, 2 November 2015, Pages 1838–1844, https://doi.org/10.1080/09168451.2015.1052773
- Share Icon Share
Abstract
Huperzia serrata has been used as a Chinese folk medicine for many years. It contains huperzine A, which has a protective effect against memory deficits in animal models; however, it is unclear if H. serrata extract exerts any effects in Alzheimer’s disease (AD) models. We used H. serrata collected in Japan and determined its huperzine A content using HPLC. We determined its inhibitory effects on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity. H. serrata extract (30 mg/kg/day) and donepezil (10 mg/kg/day) were orally administrated for 7 days. After repeated administration, we performed the Y-maze and passive avoidance tests. H. serrata extract contained 0.5% huperzine A; H. serrata extract inhibited AChE, but not BuChE. H. serrata extract ameliorated cognitive function in mice. These results indicate that Japanese H. serrata extract ameliorates cognitive function deficits by inhibiting AChE. Therefore, H. serrata extract may be valuable for the prevention or treatment of dementia in AD.
Repeated treatment with Huperzia serrata extract (30 mg/kg/day) for six or seven days ameliorated the memory impairment induced by scopolamine in the two behavioral tests.